NMR Fragment-Based CTLA-4 Targeted Small Molecule Drug Discovery

0 votes
asked Jan 27, 2022 in Cell Tracking by creativebiolabs22 (11,840 points)

Creative Biolabs provides a full range of immune checkpoint antibody development services from antibody discovery to preclinical trials in a timely and cost-effective manner. Our featured services include monoclonal antibody development, phage display antibody library construction and screening, antibody humanization, antibody production, bispecific antibody development, and so on. Besides, we also support immune checkpoint small molecule drug development and immune checkpoint assays to meet your specific requirement. Moreover, we also provide a series of high-quality immune checkpoint-related products to support your immune checkpoint research and drug discovery projects.

NMR Fragment-Based CTLA-4 Targeted Small Molecule Drug Discovery

Please log in or register to answer this question.

Welcome to Bioimagingcore Q&A, where you can ask questions and receive answers from other members of the community.
...